March 2019 | Volume 1


What should device companies consider when attempting to grow their business with providers? Three hospital administrators answer.

The transaction accelerates Corin's growth strategy and gives it a greater foothold in the U.S.

Experts provide their take on validation-related questions, from process challenge parameters to material handling.

Register by March 31
and save $100!
Meet new partners and find solutions to orthopedic device commercialization challenges!

June 11-13 | Chicago

Aakash Agarwal, Ph.D., Director of R&D at Spinal Balance, shares insights on how the Libra pedicle screw system eliminates contaminants from an implant's surface.

Aesculap Biologics achieved 50% enrollment in an ongoing Phase III trial of NOVOCART 3D, an autologous chondrocyte transplantation system designed to treat knee articular cartilage defects.

The Dual Expanding Interbody Fusion system, which opens laterally, then vertically, is in limited U.S. launch and will be released fully in 2Q19.

The device has been listed with FDA and is now available in the U.S. for use in some of the most common orthopedic surgical procedures.

How and why automation will empower your engineers and improve you company culture, while increasing your speed and quality.

See our team in ORTHOWORLD Booth 659. 
We'll have a comfortable seat and an ear for your challenges!

Search orthopedic suppliers by capability, certification and geographic region. Notice the OMTEC badge for those companies exhibiting in June, and begin to set up your meetings!